Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Ecolab, Cargill And Techstars Launch Accelerator Program

Published 12/18/2017, 08:05 PM
Updated 07/09/2023, 06:31 AM
ECL
-
IDXX
-
LMNX
-
PETS
-

Ecolab Inc. (NYSE:ECL) , Techstars and the world’s largest private agricultural company,­ Cargill, recently announced the launch of a accelerator program in Minnesota. The program is called ‘Farm to Fork Accelerator’.

The three-month program aims at integrating innovative ideas from other companies that are focused on agriculture, food-based digital technology, food processing and food safety.

Notably, 30 high-potential companies will be selected for the program that will receive monetary investment and mentoring from Ecolab and Cargill experts over the next three years. These companies can also leverage on Techstars’ global network.

Notably, the application process for the program opens in January 2018. The program will begin from July 2018.

Market Potential

The global population has quadrupled in this century. Per reports, the world will require 35% more food than the current period by 2030. The Farm to Fork Accelerator will enable companies upgrade technologies to meet the growing demand.

Factors including climate change, urbanization along with lack of investment and production have been major concerns for food companies. The program introduced by Ecolab, Cargill and the Techstars is expected to improve the current situation.

Ecolab Inc. Price

Acquisitions in Focus

The latest development closely follows Ecolab’s acquisition of Scotland-based Arpal Group. Arpal provides cleaning and sanitizing products and services in the United Kingdom and the Middle East.

The MedTech major announced the acquisition of three U.S. pest services companies that provide specialized services in food storage. The transactions are worth $36 million and were closed on Dec 1. The acquired companies are Food Protection Services LLC, Royal Pest Solutions, Inc. and Research Fumigation Company, LLC. The development expands Ecolab’s pest elimination solutions for the food and beverage industry.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

In September, the company signed an agreement to acquire the paper chemicals business of Georgia-Pacific. The deal will enhance Ecolab’s position in the growing Tissue and Towel as well as the Packaging and Board segments of the paper industry.

Price Performance

Year to date, Ecolab’s stock has traded above the industry. The company has returned almost 15.1% compared with the industry’s rally of 10.6%. Ecolab continues to witness improvement in underlying sales volume and pricing in most business segments.

A robust product portfolio, launches and expanding customer base is likely to drive organic sales, while the realization of targeted synergies associated with acquisitions will expand margins. Further, solid performance in the company’s Global Institutional segment is a positive. Sales increased 6.6% to $1.22 billion at the segment in the last quarter, courtesy of strong growth in the Specialty and Healthcare business lines.

Zacks Rank & Key Picks

The stock has a Zacks Rank #3 (Hold). A few better-ranked stocks in the broader medical sector are PetMed Express (NASDAQ:PETS) , Luminex Corporation (NASDAQ:LMNX) and IDEXX Laboratories (NASDAQ:IDXX) .

Notably, PetMed Express flaunts a Zacks Rank #1 (Strong Buy). The company has a long-term expected earnings growth rate of 10%. You can see the complete list of today’s Zacks #1 Rank stocks here.

Luminex yielded a return of 6.4% over the last year. The stock sports a Zacks Rank #1.

IDEXX Laboratories has a long-term expected earnings growth rate of 19.8%. The stock rose 39.2% over a year’s time and carries a Zacks Rank #2 (Buy).

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Zacks Editor-in-Chief Goes ""All In"" on This Stock

Full disclosure, Kevin Matras now has more of his own money in one particular stock than in any other. He believes in its short-term profit potential and also in its prospects to more than double by 2019. Today he reveals and explains his surprising move in a new Special Report.

Download it free >>



PetMed Express, Inc. (PETS): Free Stock Analysis Report

Ecolab Inc. (ECL): Free Stock Analysis Report

Luminex Corporation (LMNX): Free Stock Analysis Report

IDEXX Laboratories, Inc. (IDXX): Free Stock Analysis Report

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.